This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Bayer opposes reviving Tevra's US antitrust claims over tick treatments

( September 10, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Bayer Healthcare asked a US appeals court to affirm orders against Tevra Brands’ antitrust case over topical flea and tick treatments. “Tevra’s lawsuit was premised on several questionable assumptions, including its insistence that the relevant market was limited to imidacloprid topicals and did not include fipronil topicals (like Frontline) or any other flea and tick treatments,” it argued. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections